← Back to Clinical Trials
Recruiting NCT06494033
NCT06494033 Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT06494033 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | Lung Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-07-03 |
| Primary Completion | 2026-12-30 |
Trial Parameters
Condition Lung Diseases
Sponsor University of Miami
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2024-07-03
Completion 2026-12-30
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The purpose of this study is to evaluate the clinical outcomes of Cytomegalovirus (CMV) virus in the participants' body. Therefore, the study team will follow the participants' immunological response based on the Cytomegalovirus (CMV) virus testing.
Eligibility Criteria
Inclusion Criteria: 1. Adult patients over 18 years of age 2. Lung transplant candidates with positive CMV IgG 3. Anticipated to receive a lung transplant (both double lung and single lung) Exclusion Criteria: 1. Negative CMV IgG prior transplant 2. Pregnant or breastfeeding women 3. HIV infected patients 4. Combined organ (e.g., lung-heart, lung-kidney) transplant candidates
Related Trials
NCT05596786
Evaluation of Efficacy and Safety of Rituximab in Patients With Progressive Interstitial Lung Diseas
View Trial →
NCT06494033
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in
View Trial →
NCT05525312
Comparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Rese
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology